The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infection, antibody response and gamma globulin components in multiple myeloma and macroglobulinemia
Fahey, J. L., Scoggins, R. B., Utz, J. P., & Szwed, C. F. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90140-2 · Cited by 230
Effect of high-dose intravenous immunoglobulin therapy on blood rheology
Reinhart, W. H., & Berchtold, P. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)90806-e · Cited by 208
Biphasic Pattern of Bacterial Infection in Multiple Myeloma
Savage, D. G., LINDENBAUM, J., & GARRETT, T. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-47 · Cited by 142
Infections Complicating Multiple Myeloma and Chronic Lymphocytic Leukemia
Twomey, J. J. (1973) · Archives of Internal Medicine · doi:10.1001/archinte.1973.03650100076014 · Cited by 139
Influence of treatment and response status on infection risk in multiple myeloma
Perri, R. T., Hebbel, R. P., & Oken, M. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90303-x · Cited by 117
Prognostic features in the third MRC myelomatosis trial.
Medical Research Council's Working Party on Leukaemia in Adults (1980) · British Journal of Cancer · doi:10.1038/bjc.1980.330 · Cited by 99
High-dose intravenous IgG treatment and renal function
Schifferli, J. A., Leski, M., Favre, H., Imbach, P. A., Nydegger, U., & Davies, K. A. (1991) · The Lancet · doi:10.1016/0140-6736(91)93395-p · Cited by 92
PART I. ANALYSIS OF PRESENTING FEATURES OF PROGNOSTIC IMPORTANCE
(1973) · British Journal of Haematology · doi:10.1111/j.1365-2141.1973.tb05733.x · Cited by 89
Current Patterns of Bacterial Infection in Myelomatosis
Espersen, F., Birgens, H., HERTZ, J. B., & Drivsholm, A. (1984) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548409087137 · Cited by 28
Cited by
van de Donk, N. W. C. J., Pawlyn, C., & Yong, K. L. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00135-5 · Cited by 869
Update on the use of immunoglobulin in human disease: A review of evidence
Perez, E. E., Orange, J. S., Bonilla, F., Chinen, J., Chinn, I. K., Dorsey, M., El-Gamal, Y., Harville, T. O., Hossny, E., Mazer, B., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.023 · Cited by 666
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Blimark, C., Holmberg, E., Mellqvist, U.-H., Landgren, O., Bjorkholm, M., Hultcrantz, M., Kjellander, C., Turesson, I., & Kristinsson, S. Y. (2015) · Haematologica · doi:10.3324/haematol.2014.107714 · Cited by 524
Augustson, B. M., Begum, G., Dunn, J. A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A., Child, J. A., & Drayson, M. T. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2086 · Cited by 488
Durie, B. G. M., Kyle, R. A., Belch, A., Bensinger, W., Blade, J., Boccadoro, M., Anthony Child, J., Comenzo, R., Djulbegovic, B., Fantl, D., et al. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200312 · Cited by 427
Metadata
- Authors
- Chapel, H. M., Lee, M., Hargreaves, R., Pamphilon, D. H., Prentice, A. G., Chapel, H. M., Hargreaves, R., Lee, M., Pamphilon, D. H., & Prentice, A. G.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1994-04
- Volume
- 343
- Issue
- 8905
- Pages
- 1059-1063
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1994717499
- Cited by
- 260
- References
- 10
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. https://app.cochat.ai/papers/10.1016/s0140-6736(94)90180-5
- The paper
- Chapel, H. M., Lee, M., Hargreaves, R., Pamphilon, D. H., Prentice, A. G., Chapel, H. M., Hargreaves, R., Lee, M., Pamphilon, D. H., & Prentice, A. G. (1994). Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The Lancet. https://doi.org/10.1016/s0140-6736(94)90180-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.